Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-25-125201
Filing Date
2025-12-30
Accepted
2025-12-30 16:00:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A tm2534261d1_s3a.htm S-3/A 345073
2 EXHIBIT 23.1 tm2534261d1_ex23-1.htm EX-23.1 2392
  Complete submission text file 0001104659-25-125201.txt   348561
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-288595 | Film No.: 251614161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)